Modern views on the correction of violations of the vaginal biotope in perimenopause

Abstract

ABSTRACT. Ensuring the quality of life of women in the climacteric period remains today the most urgent problem of modern medicine. The goal is to evaluate the effectiveness of the antiseptic Ginodec in the treatment of mixed vulvovaginal infection in perimenopausal women. Materials and methods. We monitored 52 patients with mixed bacterial and candidal infection aged 44 to 52 years. The diagnosis of non-specific bacterial and candidal infection was verified according to the data of clinical and laboratory research methods. The criteria for the effectiveness of the treatment were complete clinical and bacterial sanitation. Patients with bacterial candidal infection received 5 ml of Ginodek vaginal gel once a night for 7 days. The results. Analysis of clinical effectiveness after treatment showed that in perimenopausal women, complaints of vaginal discomfort and vaginal discharge decreased by 4 times, dyspareunia was noted by only 5.8 % of patients compared to 69.2 % before treatment. Regenerative efficiency of vaginal epithelial cells in patients also improved, their maturity index increased to 75-80. Bacteriological examination carried out 2 weeks after the end of the course of treatment confirmed the effectiveness of the Ginodek drug against bacterial infection in 92.3 % of cases, candidal - in 86.5 %. Conclusions. Bacterial-fungal associations of microorganisms in the vaginal biotope in women in the perimenopausal period lead to the formation of a complex complex of unclear clinical symptoms, which makes it difficult to make a timely diagnosis. The drug Ginodek demonstrates high microbiological effectiveness in mixed bacterial-candidal infection in patients in perimenopause, and also increases the functional activity of the epithelium of the mucous membrane of the vagina, which is especially important in this period of a woman's life.